Sapiens International Corporation N.V. (NASDAQ:SPNS) has been upgraded to Hold in a report by Zacks Investment Research today.
- Updated: October 8, 2016
Having a price of $12.88, Sapiens International Corporation N.V. (NASDAQ:SPNS) traded -0.16% lower on the day. With the last close up 2.81% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. SPNS has recorded a 50-day average of $13.41 and a two hundred day average of $12.51. Trade Volume was up over the average, with 54,059 shares of SPNS changing hands over the typical 34,548
Zacks Investment Research has upgraded Sapiens International Corporation N.V. (NASDAQ:SPNS) to Hold in a report released on 10/6/2016.
Recent Performance Chart
Sapiens International Corporation N.V. has PE ratio of 30.12 with a one year low of $8.93 and a one year high of $14.13 and has a market capitalization of $0.
General Company Details For Sapiens International Corporation N.V. (NASDAQ:SPNS)
Sapiens International Corporation N.V. (Sapiens) is a provider of software solutions for the insurance industry, with a focus on the financial services sector. The Company operates in provider of software solutions segment. Its software solutions portfolio consists of Life, Pension, Annuity and Retirement Solutions, including software solutions for the management of a range of products for life, pension, annuity and retirement; Property and Casualty/General Insurance Solutions, including a software suite of solutions, supporting a range of business lines, including personal, commercial and specialty lines, as well as a solution for the management of reinsurance contracts; Sapiens DECISION, which is a business decision management solution, and Technology-Based Solutions, such as Sapiens eMerge. Its services include project delivery and implementation, business and technical consulting related to its products, project and program management, training and user acceptance testing.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.